Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
about
Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANAA Central Role for STAT3 in Gammaherpesvirus-Life Cycle and -DiseasesMolecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.Augmented latent membrane protein 1 expression from Epstein-Barr virus episomes with minimal terminal repeatsLatent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells.Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice.Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Enhanced IL-6/IL-6R signaling promotes growth and malignant properties in EBV-infected premalignant and cancerous nasopharyngeal epithelial cells.Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of Epstein-Barr virus-positive natural killer cell lymphoma.Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathwaysThe heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Technology insight: Applications of emerging immunotherapeutic strategies for Epstein-Barr virus-associated malignancies.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosisInduction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell FactorNF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.Ablation of STAT3 in the B Cell Compartment Restricts Gammaherpesvirus Latency In Vivo.Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes.Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemiaB lymphocytes from patients with a hypomorphic mutation in STAT3 resist Epstein-Barr virus-driven cell proliferationEpstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.The role of STAT5 in the development, function, and transformation of B and T lymphocytes.Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.Switching of EBV cycles between latent and lytic states.Regulation of Epstein-Barr virus reactivation from latency.Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expressionInterleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targetsEpstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cellsHigh frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.Epstein-Barr virus regulates STAT1 through latent membrane protein 1.
P2860
Q24299259-B40FB5B8-28BE-46A9-9C74-F770E7BCA24FQ26741576-0AE3388A-80F9-46C8-8EE0-E9FE164FE261Q30610963-A37172DF-AFB7-4095-8248-B8AB49AADF38Q30837949-9123BDD0-152D-44EE-BC0F-0680469B1F04Q33640213-DB030009-AC73-47BE-9501-3F8879AF4275Q33649035-35043ADE-23C2-461E-B5D0-1FB4A7D72745Q33724152-0882887B-B529-49B4-B303-F006724DFFBEQ33754907-E3B88EE6-D86C-4B94-A79C-296C7BACD5B6Q34032212-884407C5-2C72-4875-93D8-14FFC4CDB194Q34052180-658252BB-8DB0-463B-8651-BDB59AFDF6CCQ34658852-373060BB-6199-40FE-A05D-CF2776766141Q34712473-02EED7DF-7476-438A-AF0E-59ECE49877F0Q34713316-57356FA1-AF37-407A-99AC-883AAC411F15Q35051575-53BC83B9-4800-40B4-9DBC-89F14D8A550EQ35336213-479F3186-A7B5-4F81-952C-C51E09D50DC3Q35659991-DA5824F6-53A3-4EF5-9261-8D65B753BFDBQ36303951-93B1BD05-23B4-45DA-96C8-D338A98B0392Q36498181-7DD1AD4F-B911-4FD3-9D14-FD6A80FFEFC9Q36670981-B71861E4-B030-496B-ABCB-B1CDA0875905Q36736410-53EF4820-F935-4504-9C4A-DAA006F88D4DQ37073277-B1EA040B-FFF2-4EDF-9282-F89750A48925Q37168674-70997A5C-60E4-4686-8AD2-BF414BEDE886Q37252690-7210DF27-F20D-4766-8EE0-B2565F5AFF68Q37321119-A3C5DB7B-28EF-4030-B081-18BB593970C3Q37547616-A47E546F-BC2A-4983-B15A-62CF4969F45DQ37595549-23DEE280-C17D-448B-9A7C-30623D6F9F16Q37596540-8A85838B-B3CE-4931-A20E-959CC4FAFDB0Q37833131-2E6BAE1D-400B-4C14-BC17-7DD1FBE5B690Q38043974-0B630250-F119-4CD9-A2D2-DD36812D513AQ38171455-0572D6DF-3AC0-4398-9466-3DAC72DA5727Q38208532-87A91838-0A98-4D14-9868-138BEB997324Q38358818-DE32394A-6FC2-4FF3-88B6-EF69FB9C1E70Q38599063-A4059AE0-5D6A-4D13-AED2-083D5AFAECA5Q38610363-13C08D38-2279-4649-A222-902985BF5E8AQ38724665-84A71F3A-24F2-470D-A12E-403D34B08D5BQ38741546-B14C2631-F056-4300-B2B1-C281C59039C8Q38961888-90A24D9B-60AF-4B6F-9A99-85F3A9B2E728Q39147267-6F09D8D3-51D3-4371-993C-4D39D8C70AD4Q39604074-2D5A9266-2674-4F60-9179-89101949E0BBQ39736747-CDD6157F-FA54-45AA-A859-4DAE9DBB8E9A
P2860
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@ast
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@en
type
label
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@ast
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@en
prefLabel
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@ast
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@en
P2093
P2860
P1433
P1476
Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
@en
P2093
M Borowitz
R F Ambinder
S D Hayward
P2860
P304
P356
10.1128/JVI.75.6.2929-2937.2001
P577
2001-03-01T00:00:00Z